[1]Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2017 and 2045\[J\]. Diabetes Res Clin Pract,2018,138:271-281.[2]Staiger H, Machicao F, Fritsche A, et al. Pathomechanisms of type 2 diabetes genes\[J\]. Endocr Rev,2009,30(6):557-585.[3]AbuFarha M, Abubaker J, Tuomilehto J, et al. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases\[J\]. Diabetes Metab Res Rev,2017,33(8):e2919.[4]Siddiqa A, Cirillo E, Tareen SHK, et al. Visualizing the regulatory role of Angiopoietinlike protein 8 (ANGPTL8) in glucose and lipid metabolic pathways\[J\]. Genomics,2017,109(5/6):408-418.[5]Li E, Nakata M, Shinozaki A, et al. Betatrophin expression is promoted in obese hyperinsulinemic type 2 but not type 1 diabetic mice\[J\]. Endocr J,2016,63(7):611-619.[6]Rong GX,Li WX,Chen Y,et al.ANGPTL8/betatrophin alleviates insulin resistance via the AktGSK3β or AktFoxO1 pathway in HepG2 cells\[J\]. Exp Cell Res,2016,345(2):158-167.[7]Hu H,Sun W,Yu S,et al.Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients\[J\]. Diabetes Care,2014,37(10):18-22.[8]Ghasemi H, Karimi J, Khodadadi I, et al. Association between rs2278426 (C/T) and rs892066 (C/G) variants of ANGPTL8 (betatrophin) and susceptibility to type 2 diabetes mellitus\[J\]. J Clin Lab Anal,2018:e22649.[9]Guo T, Yin RX, Wu J, et al. Association of the angiopoietinlike protein 8 rs2278426 polymorphism and several environmental factors with serum lipid levels\[J\]. Mol Med Rep,2015,12(3):3285-3296.[10]Chen X,Lu P, He W, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance\[J\]. J Clin Endocrinol Metab, 2015,100(1):E96-100.[11]AlDaghri NM, Rahman S, Sabico S, et al. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters\[J\].J Diabetes Complications, 2016,30(7):1321-1325.[12]卢冰,王苏,洪霞飞,等.血清Betatrophin水平与妊娠期糖尿病的相关性研究\[J\].中国糖尿病杂志,2018(1):46-49.[13]Wang H, Lai Y, Han C, et al. The effects of serum angptl8/betatrophin on the risk of developing the metabolic syndromea prospective study\[J\]. Scientific Reports, 2016,6:28431.[14]Chant C, Susanto H, Chuang WH, et al. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function\[J\]. Cardiovasc Diabetol,2016,15(1):3.[15]Wang Y, Zhang D, Jiang Z, et al. Positive association between betatrophin and diabetic retinopathy risk in type 2 diabetes patients\[J\]. Horm Metab Res,2016, 48(3):169-173.[16]AbuFarha M, Melhem M, Abubaker J, et al. ANGPTL8/betatrophin R59W variant is associated with higher glucose level in nondiabetic Arabs living in Kuwaits\[J\].Lipids Health Dis, 2016,15(1):26.[17]Liu J, Yagi K, Nohara A, et al. High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietinlike protein 8 R59W variant\[J\].J Clin Lipidol,2018, 12(2):331-337.[18]Quagliarini F, Wang Y, Kozlitina J, et al. A typical angiopoietinlike protein that regulates ANGPTL3\[J\]. Proc Natl Acad Sci USA,2012,109(48):19751-19756. |